Hancock Jaffe Laboratories Inc ROCE
¿Qué es el ROCE de Hancock Jaffe Laboratories Inc?
El ROCE de Hancock Jaffe Laboratories Inc es -27.53%
¿Cuál es la definición de ROCE?
El retorno sobre el capital empleado (ROCE) es una relación financiera que mide la rentabilidad de una empresa y la eficiencia con la que se utiliza su capital.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de compañías en Sector Health Care en NASDAQ en comparadas con Hancock Jaffe Laboratories Inc
¿Qué hace Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Empresas con roce similar a Hancock Jaffe Laboratories Inc
- Compass tiene ROCE de -27.67%
- Lineage Cell Therapeutics Inc tiene ROCE de -27.63%
- Kuya Silver tiene ROCE de -27.62%
- Pender Street Capital Corp tiene ROCE de -27.61%
- Buckhaven Capital tiene ROCE de -27.61%
- Seagen Inc tiene ROCE de -27.58%
- Hancock Jaffe Laboratories Inc tiene ROCE de -27.53%
- Y-Mabs Therapeutics Inc tiene ROCE de -27.49%
- Ramco Systems tiene ROCE de -27.47%
- Goldflare Exploration Inc tiene ROCE de -27.46%
- Gravitas One Capital tiene ROCE de -27.44%
- Arcturus Therapeutics Inc tiene ROCE de -27.43%
- Bellus Health Inc tiene ROCE de -27.42%